These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21177785)

  • 21. Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2.
    Marx SJ; Jones G; Weinstein RS; Chrousos GP; Renquist DM
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1282-90. PubMed ID: 2555385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D deficiency as a public health issue: using vitamin D2 or vitamin D3 in future fortification strategies.
    Wilson LR; Tripkovic L; Hart KH; Lanham-New SA
    Proc Nutr Soc; 2017 Aug; 76(3):392-399. PubMed ID: 28347378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.
    Daroux M; Shenouda M; Bacri JL; Lemaitre V; Vanhille P; Bataille P
    J Nephrol; 2013; 26(1):152-7. PubMed ID: 22641581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.
    Holick MF; Biancuzzo RM; Chen TC; Klein EK; Young A; Bibuld D; Reitz R; Salameh W; Ameri A; Tannenbaum AD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):677-81. PubMed ID: 18089691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.
    Trang HM; Cole DE; Rubin LA; Pierratos A; Siu S; Vieth R
    Am J Clin Nutr; 1998 Oct; 68(4):854-8. PubMed ID: 9771862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.
    Li B; Byrjalsen I; Glendenning P; Henriksen DB; Hoeck HC; Taranto M; Vasikaran S; Fraser WD; Christiansen C; Qvist P
    Clin Chim Acta; 2009 Jun; 404(2):144-8. PubMed ID: 19336231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
    Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH
    Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
    Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
    Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease.
    Kari JA; Eldesoky SM; Bagdadi OT
    Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative antirachitic activity of vitamins D2 and D3 in the body of chicks].
    Valinietse MIu; Bauman VK
    Prikl Biokhim Mikrobiol; 1981; 17(5):712-9. PubMed ID: 6272266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial.
    Salehpour A; Shidfar F; Hosseinpanah F; Vafa M; Razaghi M; Amiri F
    Diabet Med; 2013 Dec; 30(12):1477-81. PubMed ID: 23822797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Components of 25-hydroxyvitamin D in serum of young children in upper midwestern United States.
    Arnaud SB; Matthusen M; Gilkinson JB; Goldsmith RS
    Am J Clin Nutr; 1977 Jul; 30(7):1082-6. PubMed ID: 195455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences.
    Hollis BW; Pittard WB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):652-7. PubMed ID: 6090493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin.
    Tjellesen L; Hummer L; Christiansen C; Rødbro P
    Bone; 1986; 7(5):337-42. PubMed ID: 3024685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter.
    Rapuri PB; Gallagher JC; Haynatzki G
    Calcif Tissue Int; 2004 Feb; 74(2):150-6. PubMed ID: 14648011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia.
    Heubi JE; Hollis BW; Tsang RC
    Pediatr Res; 1990 Jan; 27(1):26-31. PubMed ID: 2296467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.